Race Oncology has revealed Peter Smith will transition to become the company’s Executive Director (ASX:RAC).
This move follows the resignation of their CEO, Damian Clarke-Bruce.
Race Oncology is a specialty pharmaceutical company focused on developing treatments for rare cancers.
Global online trading services company, Plus500:
Plus500 trading platform allows you to trade shares from all popular markets such as USA, UK, Germany and more, with leverage and low spreads. Using our advanced trading tools, you can also control your profits and losses.
Plus500AU Pty Ltd, AFSL #417727 issued by Australian Securities and Investments Commission. Based in Sydney.
Receive whispers every day in your inbox.
